Health
New noninvasive biomarker can be used in the diagnosis of NAFLD – News-Medical.Net
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and can progress to liver cirrhosis, liver…
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and can progress to liver cirrhosis, liver failure or cancer. Currently, nonalcoholic steatohepatitis (NASH) diagnosis requires an invasive liver biopsy which can lead to…
Continue Reading
-
Business13 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General21 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business16 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General13 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips